Bavarian Nordic nets $160m from priority review voucher sale
Sale prices for the vouchers – which slash FDA review times for a drug – have increased in the past year as biotech funding dries up.
Tisento’s MELAS treatment receives fast track status from FDA
FDA creates new priority review voucher scheme to boost US interests
Orion and Glykos extend ADC collaboration
Novo Nordisk seeks digital health partners to boost GLP-1RA weight loss outcomes
Eli Lilly lands “bargain” deal to acquire Verve Therapeutics for $1.3bn
Analysis
View More
Themes
View MoreLisata collaborates with GATC Health on drug development
Lisata will utilise GATC's Multiomics Advanced Technology platform.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Juvenescence enhances AI drug discovery with Ro5 acquisition
Pharma’s AI prospects get nudged into the future with EU’s AI act
Next-generation targeting for evolving HCP engagement
Are regulators keeping pace with AI adoption in clinical trials?